---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-047668"
form_type: "8-K"
ticker: "FNCHQ"
cik: "0001733257"
company_name: "Finch Therapeutics Group, Inc."
filed_at: "2021-09-13T23:59:59+00:00"
generated_at: "2026-06-29T04:16:03.839971+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Finch Therapeutics posts updated corporate presentation on website

## Summary
- Presentation dated September 2021 titled 'Harnessing the Genomic Revolution & Machine Learning to Pioneer Microbiome Therapeutics'.
- Available under 'Events & Presentations' in the Investors section of the company's website.
- No specific financial or pipeline updates were disclosed in the filing; content of the slide deck is not summarized.

## SEC filing metadata
- accession: 0001564590-21-047668
- form_type: 8-K
- ticker: FNCHQ
- cik: 0001733257
- company_name: Finch Therapeutics Group, Inc.
- filed_at: 2021-09-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1733257/000156459021047668/0001564590-21-047668-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1733257/000156459021047668/fnch-8k_20210913.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-047668
- JSON: https://secwatch.observer/filing/0001564590-21-047668.json
- Plain text: https://secwatch.observer/filing/0001564590-21-047668.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.